Read the new Paper from the #CCCVienna MedUni Wien Urologic Oncology Research MedUni Vienna Tamas Fazekas MD Shahrokh F. Shariat #ProstateCancer #MRI #Oncology #Overdiagnosis #PSA #Biopsies #JAMAOncology #Screening

Vienna fellowship friendship dinner 🥳 #EAU24 Shahrokh F. Shariat Urologic Oncology Research MedUni Vienna Benjamin Pradere Keiichiro Mori Pawel Rajwa Tamas Fazekas MD Fahad Quhal فهد قحل MPallauf Nico Grossmann Takafumi Yanagisawa Tatsushi Kawada Marcin Ch

Press release: Ph3 Splash trial in mCRPC #prostatecancer with Lutetium-177-PSMA-I&T vs. ARPI/NHT switch, meets primary endpoint:⬆️rPFS: 9.5 vs 6 mos, HR 0.71. Lu-177 dose lower than PSMAfore trial with Lu-177-PSMA-617👇Link: t.ly/1Il7W OncoAlert UroToday.com Prostate Cancer Foundation

Hope this study helps the diagnostic strategy for csPCa.European Urology Oncology euoncology.europeanurology.com/article/S2588-…
Fahad Quhal فهد قحل Pawel Rajwa Benjamin Pradere Takafumi Yanagisawa Ekaterina Laukhtina Markus von Deimling Shahrokh F. Shariat

Lancetに日本の大学病院の医師の悲惨な研究環境が
・研究時間がない（講師の50％、助教授の65％が週に5時間未満。助教授の15％は0時間。）
・34％の医師が過労死ラインの年960時間以上で勤務
→大学病院の診療で食っていけて、研究できるようにしないと日本は益々衰退するthelancet.com/journals/lance…

Cytoreductive Radical Prostatectomy for Metastatic Hormone-sensitive Prostate Cancer—Evidence from Recent Prospective Reports

eu-focus.europeanurology.com/article/S2405-…

Pawel Rajwa Fabio Zattoni Martina Maggi Giancarlo Marra Shahrokh F. Shariat Alberto Briganti Francesco Montorsi Giorgio Gandaglia

#prostatecancer

📹 How does #FGFR screening assist in bladder-sparing treatment? This is the core topic of discussion between pathologist Assoc. Prof. Alessia Cimadamore & UROONCO BCa chief editor Dr. Benjamin Pradere.

Learn about their insights. Watch the interview now 👇

bladder.uroonco.uroweb.org/video/fgfr-scr…

#systematicreview #metaanalysis
🙏 A collaborative work with USC Urology
💥Interplay between Radical Cystectomy and Renal Function

📰sciencedirect.com/science/articl…

Alireza Ghoreifi, MD Takafumi Yanagisawa Tatsushi Kawada Sia Daneshmand, M.D. Dr. Hooman Djaladat Shahrokh F. Shariat

Our findings suggest that worse PS should not discourage treatment intensification across all PCa stages. BJU International Takafumi Yanagisawa Shahrokh F. Shariat Fahad Quhal فهد قحل Ekaterina Laukhtina Benjamin Pradere Urologic Oncology Research MedUni Vienna

bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…

🚨Preliminary results of the SUNRISE-1 🌅 study using TAR-200 🥨 (Gemcitabin) Sia Daneshmand, M.D.
➡️in BCG unresponsive

✨Promising results ✨
👉 72.7% of overall CR with TAR-200
👉cetrelimab does % (similar to Pembro KN057)

Gem is a great drug

#AUA23

The current role of precision surgery in oligometastatic #ProstateCancer . #BeyondTheAbstract with Markus von Deimling and Shahrokh F. Shariat. #ReadNow on UroToday > bit.ly/3GIRBNd UKE Hamburg Urologic Oncology Research MedUni Vienna

The current role of precision surgery in oligometastatic #ProstateCancer . #BeyondTheAbstract with Markus von Deimling and Shahrokh F. Shariat. #ReadNow on UroToday > bit.ly/3GIRBNd UKE Hamburg Urologic Oncology Research MedUni Vienna

The current role of precision surgery in oligometastatic #ProstateCancer . #BeyondTheAbstract with Markus von Deimling and Shahrokh F. Shariat. #ReadNow on UroToday > bit.ly/3GIRBNd UKE Hamburg Urologic Oncology Research MedUni Vienna

Prostate cancer risk, screening, and management in patients with germline BRCA1/2 mutations Nature Reviews Urology Shahrokh F. Shariat Ganesh Palapattu Alberto Briganti Todd 〽️ Morgan, MD Axel S. Merseburger Derya Tilki, MD @gorejohn Michael Leapman Ploussard Guillaume Giorgio Gandaglia Benjamin Pradere Fahad Quhal فهد قحل
nature.com/articles/s4158…

Come and join this amazing meeting on December 16 starting at 13:00 Central European time. Hybrid meeting with international superstars covering urologic cancers and urolithiasis.

December 2022 Issue

Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with ADT for mHSPC: A Systematic Review and Meta-analysis buff.ly/3QVuLE0

Editorial: Triplet Therapy: Entering the Metaverse of mHSPC Treatment buff.ly/3BQ5CpJ

We have to help each other beyond the departments.

onlinelibrary.wiley.com/share/author/D…

Check out our latest review in ESMO Open on the current role of precision surgery in omPCa
Pawel Rajwa Derya Tilki, MD Paolo Gontero Benjamin Pradere Ploussard Guillaume Michael Rink Shahrokh F. Shariat

sciencedirect.com/science/articl…

ドイツ泌尿器科学会総会🇩🇪
完全アウェイの中で発表させて頂きやした

#DGU
#お呼びじゃないのは知っている

Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk NMIBC (HIVEC-II): A Phase 2, Open-label, RCT

buff.ly/3wkud2K
Wei Shen Tan et al.

'CHT cannot be recommended over chemotherapy alone for intermediate-risk NMIBC'